Swine Flu Market Remains Cold
Cold market reaction to the effects of swine flu on the stock prices of Gilead Sciences Inc. (Nasdaq: GILD), GlaxoSmithKline (Nasdaq: GSK), and Switzerland-based Roche confirms conclusions of recent Global Pandemic Influenza Preparedness Market Forecast 2010-2015 – as fear and panic rises among governments and citizens alike, the pandemic flu preparedness market is not going through explosive growth. Investors are looking at the situation from a completely sober angle – stock prices of Gilead Sciences Inc., GlaxoSmithKline and Roche remain flat.
Only Novavax, a small player in the market, enjoyed record high stock price on news that its experimental vaccine for one strain of avian influenza produced a strong immune response in human test cases.
